Showing results (191-200 of 390) with videos related to

Sort By:
Pageof 39
Journal of Hypertension|July 24, 2015
Impaired endothelium-dependent vasodilation does not initiate the development of sunitinib-associated hypertensionAnna M J Thijs, Carla M L van Herpen, Vivienne Verweij, et al.
Palliative & Supportive Care|December 18, 2015
How did partners experience cancer patients' participation in a phase I study? An observational study after a patient's deathSimone M C H Langenberg, Marlies E W J Peters, Winette T A van der Graaf, et al.
European Heart Journal|February 16, 2006
Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam StudyAnneke de Torbal, Eric Boersma, Jan A Kors, et al.
British Journal of Clinical Pharmacology|May 3, 2020
The relationship between sunitinib exposure and both efficacy and toxicity in real-world patients with renal cell carcinoma and gastrointestinal stromal tumourKim Westerdijk, Stefanie D Krens, Winette T A van der Graaf, et al.
Molecular and Cellular Biology|February 3, 2005
Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchorsRené E M A van Herpen, Ralph J A Oude Ophuis, Mietske Wijers, et al.
BMC Health Services Research|March 31, 2022
The effect of Patient's Own Medication use on patient's self-reported medication knowledge during hospitalisation: a pre-post intervention studyLoes J M van Herpen-Meeuwissen, Bart J F van den Bemt, Hieronymus J Derijks, et al.
Plos One|February 4, 2014
The economics of dementia-care mapping in nursing homes: a cluster-randomised controlled trialGeertje van de Ven, Irena Draskovic, Elke van Herpen, et al.
The Lancet. Oncology|April 4, 2019
Dose recommendations for anticancer drugs in patients with renal or hepatic impairmentStefanie D Krens, Gerben Lassche, Frank G A Jansman, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II studyPeter Mulders, Robert Hawkins, Paul Nathan, et al.
European Heart Journal|March 11, 2006
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam studyJan Heeringa, Deirdre A M van der Kuip, Albert Hofman, et al.
Pageof 39